Australia Subcutaneous Drug Delivery Devices Market Size & Outlook
Australia subcutaneous drug delivery devices market, 2018-2030 (US$M)
Related Markets
Australia subcutaneous drug delivery devices market highlights
- The Australia subcutaneous drug delivery devices market generated a revenue of USD 535.6 million in 2023 and is expected to reach USD 1,129.6 million by 2030.
- The Australia market is expected to grow at a CAGR of 11.2% from 2024 to 2030.
- In terms of segment, prefilled syringes was the largest revenue generating product in 2023.
- Wearable injectors is the most lucrative product segment registering the fastest growth during the forecast period.
Subcutaneous drug delivery devices market data book summary
| Market revenue in 2023 | USD 535.6 million |
| Market revenue in 2030 | USD 1,129.6 million |
| Growth rate | 11.2% (CAGR from 2023 to 2030) |
| Largest segment | Prefilled syringes |
| Fastest growing segment | Wearable injectors |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Prefilled syringes, Pen injectors, Auto-injectors, Wearable injectors, Needle-free injectors |
| Key market players worldwide | Gerresheimer AG ADR, Medtronic PLC, Ypsomed Holding AG, Novo Nordisk A/S ADR, Insulet Corp, Becton Dickinson & Co, West Pharmaceutical Services Inc, PHARMAJET, Unilife Corporation |
Other key industry trends
- In terms of revenue, Australia accounted for 1.7% of the global subcutaneous drug delivery devices market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, Japan subcutaneous drug delivery devices market is projected to lead the regional market in terms of revenue in 2030.
- Japan is the fastest growing regional market in Asia Pacific and is projected to reach USD 2,758.1 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Subcutaneous Drug Delivery Devices Market Scope
Subcutaneous Drug Delivery Devices Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Australia subcutaneous drug delivery devices market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to subcutaneous drug delivery devices market will help companies and investors design strategic landscapes.
Prefilled syringes was the largest segment with a revenue share of 42.29% in 2023. Horizon Databook has segmented the Australia subcutaneous drug delivery devices market based on prefilled syringes, pen injectors, auto-injectors, wearable injectors, needle-free injectors covering the revenue growth of each sub-segment from 2018 to 2030.
The subcutaneous drug delivery devices market in Australia is expected to witness considerable growth over the forecast period. This can be attributed to improvements in cutting-edge technology, a larger patient pool, and weak regulatory standards.
In addition, the growing prevalence of chronic diseases and a rapidly aging population are some of the other key factors expected to drive market expansion.
Reasons to subscribe to Australia subcutaneous drug delivery devices market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Australia subcutaneous drug delivery devices market databook
-
Our clientele includes a mix of subcutaneous drug delivery devices market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Australia subcutaneous drug delivery devices market , including forecasts for subscribers. This country databook contains high-level insights into Australia subcutaneous drug delivery devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Australia subcutaneous drug delivery devices market size, by product, 2018-2030 (US$M)
Australia Subcutaneous Drug Delivery Devices Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
